Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:MAbs
Hoofdauteurs: Kim, HoUng, Alten, Rieke, Cummings, Fraser, Danese, Silvio, D’Haens, Geert, Emery, Paul, Ghosh, Subrata, Gilletta de Saint Joseph, Cyrielle, Lee, JongHyuk, Lindsay, James O., Nikiphorou, Elena, Parker, Ben, Schreiber, Stefan, Simoens, Steven, Westhovens, Rene, Jeong, Ji Hoon, Peyrin-Biroulet, Laurent
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2021
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889098/
https://ncbi.nlm.nih.gov/pubmed/33557682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1868078
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items